Investors
Africa is the world’s fastest-growing continent with the world’s youngest population. Its healthcare infrastructure is expanding rapidly. The burden of surgical disease — cancer, fibroids, colorectal conditions, hernias, urological disease — is enormous and growing. And the window to establish leadership in robotic surgery across this continent is open right now.
With NAFDAC approval secured, the first robotic-assisted surgeries completed, and a hospital partnership network operational in Nigeria, RoboMed™ has proven its model works. We are now positioned for the scaling phase — and we are building our investor community with care and intention.
Our model combines technology deployment, surgeon training, long-term hospital partnerships, and a diversified product marketplace to create sustainable, scalable surgical programs. By focusing on high-impact markets where demand dramatically exceeds supply, RoboMed™ is built to drive strong clinical outcomes and significant long-term value simultaneously.
We invite investors who understand that impact and returns are not opposites to join us.
RoboMed™ presents an investment case grounded in validated outcomes, documented deployments, and real-world regulatory progress — not assumptions or speculative forecasts. Every claim is supported by operational evidence, structured implementation results, and repeatable performance data from existing systems.
Expansion of robotic surgery programs to additional partner hospitals across Nigeria and West Africa
Country-by-country regulatory approval enabling entry into Ghana, Kenya, Rwanda, and beyond
Growth of the RoboMed™ Academy — more surgeons trained, more local faculty developed
Telesurgery infrastructure connecting expert surgeons with patients in underserved regions
RoboMed™ Cares programs providing subsidized surgical access to low-income communities
RoboMed™ Marketplace expansion — more products, more hospitals served, more uptime guaranteed
RoboMed™ is entering a critical scaling phase — moving from validated implementation into structured expansion across new regions and healthcare systems. This is not an early concept; it is a working model transitioning into broader deployment, with proven frameworks already in place.
At this stage, we are intentionally selective about the partners we engage. We are looking for investors who bring more than capital — those who understand long-term infrastructure building, regulatory complexity, and the patience required to scale systems that transform entire healthcare ecosystems.
Our focus is not rapid expansion at any cost, but deliberate, high-integrity growth with aligned stakeholders who see healthcare transformation as both an impact mission and a sustainable investment opportunity.